In new guidance, NICE has cleared NHS use of Boehringer Ingelheim's clot-busting therapy Metalyse as a treatment for acute ischaemic stroke in adults. The healthcare cost-effectiveness watchdog ...

In the pre-market, stocks around the world were deep in the RED, the VIX surging by 20%, and the moment the bell rang at 9:30 ...

Tenecteplase can be used, within its marketing authorisation, as an option for the thrombolytic treatment of an acute ischaemic stroke in adults ... NHS alongside evidence generation, in line with ...

According to reports, rounds at the LPGA Tour’s Founders Cup never surpassed 4.5 hours, which prompted Graeme McDowell to ...

The new guidance means that around 15 million people in England alone could be eligible for treatment. NICE estimates that ... not get heart disease or have a stroke because they take a statin.

Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...

[ID43] Technology appraisal guidance TBC Botulinum toxin type A for treating upper or lower limb focal spasticity associated with stroke [ID768] Technology appraisal guidance TBC ...

Stereotaxis gains CE Mark for MAGiC catheter, boosting revenue with high margins. FDA approval expected soon. Click here to ...

These include automatic stroke detection, lap counting ... including swims. There’s a nice new feature that allows you to connect it with compatible gym equipment to share heart rate monitoring.

Despite everything, maybe putting a GMT610 on the list of family vans to shop around for isn't the craziest thing we've ever ...

Key Tronic Corporation (NASDAQ: KTCC) Q2 2025 Earnings Call Transcript February 4, 2025 ...

Welcome to Abbott's fourth quarter 2024 earnings conference call. [Operator instructions] This call is being recorded by Abbott. With the exception of any participants' questions asked during the ...